Publications by Lab Members

Ahn JS, Petersen M, Friedman AH, López EM, Cummings TJ, Buckley AF, López GY. Eosinophilic globules in a classic ependymoma: evidence of a possible secretory role. Ultrastruct Pathol. 2020 Nov 20;44(4-6):511-518. doi: 10.1080/01913123.2020.1843578. Epub 2020 Nov 5. PMID: 33148106.

López GY, Perry A, Harding B, Li M, Santi M. CDKN2A/B Loss Is Associated with Anaplastic Transformation in a Case of NTRK2 Fusion-positive Pilocytic Astrocytoma. Neuropathol Appl Neurobiol. 2019 Feb;45(2):174-178. doi: 10.1111/nan.12503. Epub 2018 Jun 21. PubMed PMID: 29804288; PubMed Central PMCID: PMC6258357.

López GY, Van Ziffle J, Onodera C, Grenert JP, Yeh I, Bastian BC, Clarke J, Oberheim Bush NA, Taylor J, Chang S, Butowski N, Banerjee A, Mueller S, Kline C, Torkildson J, Samuel D, Siongco A, Raffel C, Gupta N, Kunwar S, Mummaneni P, Aghi M, Theodosopoulos P, Berger M, Phillips JJ, Pekmezci M, Tihan T, Bollen AW, Perry A, Solomon DA. The genetic landscape of gliomas arising after therapeutic radiation. Acta Neuropathol. 2019 Jan;137(1):139-150. doi: 10.1007/s00401-018-1906-z. Epub 2018 Sep 8. PubMed PMID: 30196423; PubMed Central PMCID: PMC6589431.

Lopez GY, Oberheim Bush NA, Phillips JJ, Bouffard JP, Moshel YA, Jaeckle K, Kleinschmidt-DeMasters BK, Rosenblum MK, Perry A, Solomon DA. Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expression. Acta Neuropathol. 2017 Dec;134(6):961-963. doi: 10.1007/s00401-017-1780-0. Epub 2017 Oct 23. PubMed PMID: 29063183; PubMed Central PMCID: PMC6078201.

López G, Oberheim Bush NA, Berger MS, Perry A, Solomon DA. Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma. Acta Neuropathol Commun. 2017 May 15;5(1):38. doi: 10.1186/s40478-017-0440-x. PubMed PMID: 28506301; PubMed Central PMCID: PMC5433088.

Lopez G, McLendon RE, Peters KB. Supratentorial tanycytic ependymoma in an adult male: case report and review of literature. Case Rep Oncol. 2015 Jan-Apr;8(1):159-63. doi: 10.1159/000380906. eCollection 2015 Jan-Apr. PubMed PMID: 25873884; PubMed Central PMCID: PMC4386143.

Feng H, Lopez GY, Kim CK, Alvarez A, Duncan CG, Nishikawa R, Nagane M, Su AJ, Auron PE, Hedberg ML, Wang L, Raizer JJ, Kessler JA, Parsa AT, Gao WQ, Kim SH, Minata M, Nakano I, Grandis JR, McLendon RE, Bigner DD, Lin HK, Furnari FB, Cavenee WK, Hu B, Yan H, Cheng SY. EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis. J Clin Invest. 2014 Sep;124(9):3741-56. doi: 10.1172/JCI73093. Epub 2014 Jul 25. PubMed PMID: 25061874; PubMed Central PMCID: PMC4151226.

Jin G, Reitman ZJ, Duncan CG, Spasojevic I, Gooden DM, Rasheed BA, Yang R, Lopez GY, He Y, McLendon RE, Bigner DD, Yan H. Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomas. Cancer Res.2013 Jan 15;73(2):496-501. doi: 10.1158/0008-5472.CAN-12-2852. Epub 2012 Nov 30. PubMed PMID: 23204232; PubMed Central PMCID: PMC3548957.

Koivunen P, Lee S, Duncan CG, Lopez G, Lu G, Ramkissoon S, Losman JA, Joensuu P, Bergmann U, Gross S, Travins J, Weiss S, Looper R, Ligon KL, Verhaak RG, Yan H, Kaelin WG Jr. Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature. 2012 Feb 15;483(7390):484-8. doi: 10.1038/nature10898. PubMed PMID: 22343896; PubMed Central PMCID: PMC3656605.

Lopez GY, Reitman ZJ, Solomon D, Waldman T, Bigner DD, McLendon RE, Rosenberg SA, Samuels Y, Yan H. IDH1(R132) mutation identified in one human melanoma metastasis, but not correlated with metastases to the brain. Biochem Biophys Res Commun. 2010 Jul 30;398(3):585-7. doi: 10.1016/j.bbrc.2010.06.125. Epub 2010 Jul 13. PubMed PMID: 20603105; PubMed Central PMCID: PMC2987603.